Introducing the expanded ChinaBio 2027 program
This year's ChinaBio program continues its strong focus on partnering while expanding to deliver a more comprehensive experience across six specialized content tracks. Whether you're focused on forging partnerships, navigating regulatory pathways, advancing clinical programs, or optimizing manufacturing operations, our expanded agenda offers the strategic knowledge and connections you need to drive innovation forward in China's dynamic biotech landscape.
Explore the program tracks at ChinaBio
The Partnering Forum
Antibody & ADC Summit
From bispecifics and ADCs to next-generation antibody discovery platforms, the Antibody Engineering & Therapeutics Summit examines what's pushing the boundaries of biologics innovation.
BioProcess International
From continuous processing to single-use technologies and digital transformation, the Bioprocess International Conference explores what's advancing biomanufacturing excellence.
Cell & Gene Therapy Summit
From CAR-T innovations to gene editing breakthroughs and scalable manufacturing solutions, the Cell & Gene Therapy Summit explores what's driving the next wave of curative medicine.
Nucleic Acid and Peptide Summit
From mRNA vaccines to siRNA therapeutics and peptide-drug conjugates, the Nucleic Acids & Peptides Summit explores what's unlocking new frontiers in precision medicine.
